We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 10, 2020

Adoptive Immunotherapy With Cord Blood Following Chemotherapy for Refractory Myeloid Malignancies

Blood advances


Additional Info

Disclosure statements are available on the authors' profiles:

Blood advances
Adoptive Immunotherapy With CB Following Chemotherapy for Patients With Refractory Myeloid Malignancy: Chimerism and Response
Blood Adv 2020 Oct 27;4(20)5146-5156, OK Chaekal, A Scaradavou, E Masson Frenet, MS Albano, M Cushing, P Desai, L Dobrila, U Gergis, D Guarneri, JM Hsu, S Lee, SA Mayer, AA Phillips, N Orfali, EK Ritchie, GJ Roboz, C Romeo, MS Samuel, T Shore, K van Besien

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading